KRAS and colorectal cancer: The IdyllaTM KRAS Mutation Assay is not intended to identify the rare mutations G12F, G13C, or G13R (<0.5% prevalence in colorectal cancer), which were previously detected in 6 archival FFPE samples by routine reference methods.